
Mesoporous polydopamine (MPDA)-based drug delivery system …
2024年11月1日 · We developed a novel oral drug delivery system designed for localized treatment of colon cancer via chemotherapy and photothermal therapy (PTT). This system …
Cisplatin-loaded mesoporous polydopamine nanoparticles capped …
2024年5月10日 · Cisplatin (CP) was loaded into mesoporous polydopamine (mPDA) nanoparticles (NPs) with a drug loading of 15.8 ± 0.1 %, and MnO2 used as pore sealing …
Multidimensional response of dopamine nano-system for on …
2024年2月15日 · In this study, we used mesoporous poly-dopamine nanoparticles (MPDA NPs) as a carrier, prochloraz (Pro) as a loading agent, and benzimidazole (BIZ) and β-cyclodextrin …
Innovative Bio‐based Hydrogel Microspheres Micro‐Cage for …
2024年4月6日 · X-ray diffraction (XRD) illustrated a high similarity in phase characteristics between mPDA and mPDA-PEI (Figure 3G), confirming the structural integrity of PDA after …
介孔聚多巴胺纳米核壳结构粒子的制备及吸附性能研究 - 豆丁网
2020年3月14日 · 本文基于介孔多巴胺(MPDA)制备了几种微纳米核壳结构粒子,四氧化三铁介孔. 聚多巴胺核壳复合纳米粒子(Fe. @MPDA)、pH响应的Fe. @MPDA复合粒子以. 及中空 …
(a) XRD patterns of the FA-(N-MPDA)PbBr4 microrod for 1, 3, 5, …
Download scientific diagram | (a) XRD patterns of the FA- (N-MPDA)PbBr4 microrod for 1, 3, 5, and 7 days. (b) The FA- (N-MPDA)PbBr4 microrod crystal shows stable PL emission without …
基于介孔聚多巴胺的微纳米药物载体的制备及其性能研究-学位-万 …
本文以安全、无毒、表面易功能化的介孔聚多巴胺(MPDA)为基体,制备了三种微纳米药物载体:Fe3O4@HMPDA、Fe3O4@HMPDA@HA以及MPDA@IR780粒子。 利用透射电 …
(a) Nitrogen adsorption-desorption isotherms; (b) pore size ...
MPdA samples calcined at different temperatures for 5 h were analyzed by X-ray diffraction (XRD). Figure 1 c displays the characteristic peaks of γ-Al 2 O 3 (JCPDS #00-029-0063) and …
RNA-Seq Based Toxicity Analysis of Mesoporous Polydopamine ...
2022年4月28日 · The morphology of MPDA NPs was measured by scanning electron microscope (SEM). The particle size and zeta potential of MPDA NPs were determined by dynamic light …
Use of mesoporous polydopamine nanoparticles as a stable drug …
See the supplementary material for XRD pattern of MPDA and immunofluorescence staining of chondrocytes. The table includes primers of targeted genes.